Status:
UNKNOWN
Efficacy of Melanostop Peeling for Improvement of Melasma
Lead Sponsor:
VIST - Faculty of Applied Sciences
Conditions:
Melasma
Eligibility:
FEMALE
20-50 years
Phase:
NA
Brief Summary
Participants with face melasma will receive 4 Melanostop peel treatments containing 20% azelaic acid, 10% resorcinol and 6% phytic acid. Peels will be performed at 2-week interval. They will also rece...
Eligibility Criteria
Inclusion
- Adult women aged between 20-50 years old.
- Melasma on the face
- Fitzpatrick phototypes I-IV
- Presenting facial melasma
- In good health condition
Exclusion
- Breastfeeding and pregnancy
- Women presenting oral herpes
- Other skin diseases, arthritis, diabetes, diseases of thyroid gland
- Any known allergies to ingredients of the products used in the study
- Systemic or topical use of corticosteroids in the previous 6 months
- Antiaging or lightening cosmetic/estetic procedures in the last 2 months (for example: laser or IPL treatments, chemical peels,..)
- Taking drugs for skin lightening in the previous 2 months
- Smoking
- Lesions of unknown origin
- Oral or topical use of isotretinoin in the previous 6 months
- Active bacterial, viral or fungal infections of the skin
- Presence of keloid scars
- Immunodeficiency
- Moderate to severe acne
- Planned change in hormonal contraception or taking drugs that have an affect on hormonal balance during the course of the study
- Unrealistic expectations
- Refusal to use sunscreen protection and complying with instructions
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03826277
Start Date
February 1 2019
End Date
December 1 2024
Last Update
April 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Higher School of Applied Sciences, Institute of Cosmetics
Ljubljana, Slovenia, 1000